Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM-PRP-HA Versus HA in Knee Osteoarthritis
NCT05076526Phase 3Unknown
- Sponsor
- Singapore General Hospital
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Cell Therapies, Device-based Delivery
01
Overview
A Phase 3 trial of Cellular Matrix-BCT-HA in knee osteoarthritis (OA), sponsored by Singapore General Hospital. Status: unknown.
02
Drugs
Cellular Matrix-BCT-HA
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05076526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076526.